Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone in HIV-Associated Nephropathy (HIVAN)
NCT00000819Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in HIV-associated nephropathy (HIVAN) comparing Prednisone with Placebo (2 arms). Primary endpoints: Serum creatinine level at 24 weeks, Urinary protein level at 24 weeks and 1 more. Status: completed.
02
Drugs
prednisone
03
Conditions
HIV-associated nephropathy (HIVAN)
Beyond the preview
Go deeper on NCT00000819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000819.